Cytokinetics CEO Robert I. Blum disposes of USD 490,950 in common shares

Bitget2026/09/28 20:55

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Cytokinetics President and CEO Robert I. Blum exercised stock options for 7,500 shares at USD 10.6 on Sept. 28, 2026.
Blum sold 7,500 shares at USD 65.46 the same day.
Directly held common shares totaled 278,544 following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytokinetics Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001061983-26-000097), on September 28, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Cytokinetics CEO Robert I. Blum disposes of USD 490,950 in common shares

You may also like

Crypto prices